Paraneoplastic Antibodies (PCCA/ANNA) by IFA with Reflex to Titer and Immunoblot, CSF
2010841
Ordering Recommendation
 
Mnemonic
PCCAANNA C
Methodology
Semi-Quantitative Indirect Fluorescent Antibody/Qualitative Immunoblot
Performed
Wed
Reported
1-9 days  
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
CSF  
Specimen Preparation
Transfer 2 mL CSF to an ARUP Standard Transport Tube. (Min: 0.75 mL)  
Storage/Transport Temperature
Refrigerated  
Unacceptable Conditions
Contaminated, heat-inactivated, hemolyzed, or lipemic specimens.  
Remarks
  
Stability
Ambient: 24 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)  
Reference Interval
 
 
Test Number Components Reference Interval
 Paraneoplastic Abs (PCCA/ANNA) IgG, CSFNone Detected
 Neuronal Nuclear Ab Titer, IgG CSFLess than 1:1
 Purkinje Cell Antibody Titer IgG, CSFLess than 1:1
 Neuronal Nuclear Abs IgG ImmunoBlot, CSFNone Detected
Interpretive Data


See Compliance Statement D: www.aruplab.com/CS  
Note
PCCA/ANNA antibodies are screened by IFA. If the IFA screen is positive at 1:1, then a specific titer (PCCA or ANNA) and Immunoblot will be added. Additional charges apply.
CPT Code(s)
86255; if reflexed add 86256 and 83516
Components
Component Test Code*Component Chart Name
2010842Paraneoplastic Abs (PCCA/ANNA) IgG, CSF
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases